1. Home
  2. C vs JNJ Comparison

C vs JNJ Comparison

Compare C & JNJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Citigroup Inc.

C

Citigroup Inc.

HOLD

Current Price

$134.65

Market Cap

220.2B

Sector

Finance

ML Signal

HOLD

Logo Johnson & Johnson

JNJ

Johnson & Johnson

HOLD

Current Price

$236.22

Market Cap

542.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
C
JNJ
Founded
1812
1886
Country
United States
United States
Employees
226000
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
220.2B
542.4B
IPO Year
N/A
2003

Fundamental Metrics

Financial Performance
Metric
C
JNJ
Price
$134.65
$236.22
Analyst Decision
Buy
Buy
Analyst Count
16
20
Target Price
$134.94
$238.20
AVG Volume (30 Days)
7.5M
6.2M
Earning Date
04-14-2026
04-14-2026
Dividend Yield
1.88%
2.36%
EPS Growth
N/A
90.50
EPS
N/A
2.14
Revenue
N/A
N/A
Revenue This Year
$24.26
$6.63
Revenue Next Year
$3.63
$7.43
P/E Ratio
$16.63
$108.58
Revenue Growth
N/A
N/A
52 Week Low
$76.11
$149.04
52 Week High
$135.83
$251.71

Technical Indicators

Market Signals
Indicator
C
JNJ
Relative Strength Index (RSI) 63.74 61.48
Support Level $94.96 $233.83
Resistance Level N/A $246.40
Average True Range (ATR) 3.45 4.20
MACD 0.84 0.96
Stochastic Oscillator 90.34 93.60

Price Performance

Historical Comparison
C
JNJ

About C Citigroup Inc.

Citigroup is a global financial powerhouse that orchestrates the movement of $5 trillion in daily transaction volume, serving as the essential connective tissue for the world's most complex multinational corporations. The firm remains a leader on the global stage, servicing 90% of the Fortune 500 through a proprietary network that includes direct membership to over 270 cash-clearing centers and a footprint that spans 94 countries. After a checkered history operating as an overly complex, disjointed firm, steps have been taken to streamline operations, resulting in organization across five segments: services, markets, banking, wealth, and US personal banking.

About JNJ Johnson & Johnson

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.

Share on Social Networks: